The potential radio-immunotherapeutic α-emitter
(227)Th
Coincidence
DCC
Ionisation chambers
Liquid Scintillation
Nuclear Medicine
Radioactive Ingrowth
Radioactivity
Radioimmunotherapy
Standardisation
Journal
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
08
06
2018
revised:
20
11
2018
accepted:
07
12
2018
pubmed:
26
12
2018
medline:
26
7
2019
entrez:
26
12
2018
Statut:
ppublish
Résumé
Thorium-227 is a potential therapeutic radionuclide for applications in targeted α-radioimmunotherapy for the treatment of various types of cancer. To provide nuclear medicine departments involved in Phase I clinical trials traceability to the SI unit of radioactivity (Bq), a standardisation of a radiochemically pure
Identifiants
pubmed: 30583971
pii: S0969-8043(18)30534-7
doi: 10.1016/j.apradiso.2018.12.012
pii:
doi:
Substances chimiques
Radiopharmaceuticals
0
Thorium-227
0
Germanium
00072J7XWS
Thorium
60YU5MIG9W
Types de publication
Journal Article
Langues
eng
Pagination
240-250Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.